Acer Therapeutics Inc. — Form D
Acer Therapeutics Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-04. The offering totals $15.7M, of which $15.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-10-04
- Form: D
- Accession: 0001638234-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.7M
- Amount sold: $15.7M
- Investors: 10
- Date of first sale: 2017-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-295986
Issuer
- Name: Acer Therapeutics Inc.
- CIK: 0001638234
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 222 THIRD STREET, SUITE 2240, CAMBRIDGE, MA, 02142
- Phone: 844-902-6100
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Stephen Aselage | Director | Newton, MA |
| Hubert Birner | Director | Cambridge, MA |
| John Dunn | Director | Salt Lake City, UT |
| Luc Marengere | Director | Roseville, MN |
| Christopher Schelling | Director | Cambridge, MA |
| Harry S Palmin | Executive Officer | Newton, MA |
| Christopher Schelling | Executive Officer | Cambridge, MA |
| Robert S Steiner | Executive Officer | Cambridge, MA |
| Harry S Palmin | Director | Newton, MA |
| Harry S Palmin | Promoter | Newton, MA |
| Christopher Schelling | Promoter | Cambridge, MA |
| Harry Palmin | Promoter | Cambridge, MA |
| Cynthia Lavoie | Director | Cambridge, MA |
| Cynthia S Lavoie | Director | Cambridge, MA |
| Christopher S Schelling | Director | Cambridge, MA |
| Christopher S Schelling | Executive Officer | Cambridge, MA |
| Christopher S Schelling | Promoter | Cambridge, MA |
Other filings by this issuer (4)
More